|No.||Institution||Short name||City, Country||Type||Sector||Scientist-in-charge|
|1.||University of Novi Sad||UNS||Novi Sad, Serbia||AC||Academic||Goran Stojanović|
|2.||Elvesys SAS||ELV||Paris, France||MS||SME||Guilhem V. Casquillas|
|3.||Marcotech oHG||MAR||Muenster, Germany||MS||SME||Lothar Heinrich|
|4.||Genochem SAS||GEN||Grasse, France||MS||SME||Cedric Poinsard|
|5.||Prince Songkla University||PSU||Songkla, Thailand||TC||Academic||Somyot Chirasatitsin|
|6.||Curtin University||CUU||Perth, Australia||TC||Academic||Hani Al-Salami|
The Elvesys SAS The Elvesys SAS is an innovative company created in 2011 which develops and provides microfluidic chips and scientific instruments for microfluidic researches. With 10 researchers in microfluidic, Elvesys now proposes the world widest brand of microfluidic flow control products. Through its brand Elveflow, Elvesys is the world leader for high precision microfluidic flow control instruments. The second main mission of Elvesys is to enhance the technological transfer of microfluidic innovations from research laboratories to the market. Laureate of the World Innovation 2030 Challenge, Elvesys was recognized as one of the 100 future champions of the French economy and our proprietary FASTGENE microfluidic technology was chosen by the government to radically change the future of personalized medicine.
Key personnel: Dr Guilhem Velvé-Casquillas, Dr Adrien Plecis, Dr Maël Le Berre.